Bascom Palmer Eye Institute
Bascom Palmer Eye Institute
Miami, Florida, United States17 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Suprachoroidal Administration in Subjects With Metastases to the Choroid | Neoplasms by Site, eye disorder, neoplasm, ocular cancer | Recruiting | Phase 2 | 2026-10-08 | NCT06643884 | |
| Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Juvenile Macular Degeneration, Stargardt Disease 1, Stargardt disease, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-07 | NCT06467344 | |
| ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis | eye disorder, retinal degeneration, retinal disorder, retinoschisis | Recruiting | Phase 3 | 2026-09-29 | NCT05878860 | |
| Clinical Applications of Advanced Ophthalmic Imaging | CNS demyelinating autoimmune disease, Diabetes Complications, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, cardiovascular disorder, central nervous system disorder, cognitive disorder, dementia, demyelinating disease, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, dry eye syndrome, endocrine system disorder, eye disorder, immune system disorder, lacrimal apparatus disorder, multiple sclerosis, myopia, nervous system disorder, presbyopia, psychiatric disorder, refractive error, retinal disorder, vascular disorder | Recruiting | Not applicable | 2026-09-16 | NCT03135327 | |
| A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Stargardt disease, eye disorder, hereditary disease, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-07-31 | NCT05956626 | |
| Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis | non-infectious anterior uveitis | Recruiting | Phase 2 | 2026-07-28 | NCT07285070 | |
| Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye | dry eye syndrome, eye disorder, lacrimal apparatus disorder | Recruiting | Phase 2 | 2026-07-24 | NCT07413172 | |
| A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer | HER2-positive Breast Cancer | Active, not recruiting | Phase 3 | 2026-07-23 | NCT03975647 | |
| Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial | eye disorder, glaucoma, ocular hypertension | Recruiting | Not applicable | 2026-07-14 | NCT05924477 | |
| A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa | Eye Diseases, Hereditary, eye disorder, retinal degeneration, retinal disorder | Active, not recruiting | Phase 2 | 2026-06-25 | NCT07174726 | |
| Plasma Rich in Growth Factors in Corneal Endothelial Transplantation | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Fuchs' endothelial dystrophy, corneal disorder, corneal dystrophy, corneal edema, eye disorder, hereditary disease | Recruiting | Not applicable | 2026-04-09 | NCT06261346 | |
| Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye | Diabetes Complications, Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus, type 2 diabetes mellitus | Recruiting | Phase 1 / Phase 2 | 2026-03-12 | NCT02846571 | |
| An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Stargardt disease, eye disorder, hereditary disease, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Not stated | 2025-09-19 | NCT06435000 | |
| EyeConic: Qualification for Cone-Optogenetics | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder | Recruiting | Not stated | 2025-07-31 | NCT05294978 | |
| A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Stargardt disease, eye disorder, hereditary disease, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 / Phase 2 | 2025-04-29 | NCT06942572 | |
| Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, Hashimoto thyroiditis, autoimmune disease, autoimmune thyroid disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder, thyroiditis | Recruiting | Phase 2 / Phase 3 | 2025-02-25 | NCT06112340 | |
| A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN) | Eye Diseases, Hereditary, eye disorder, retinal degeneration, retinal disorder | Enrolling by invitation | Phase 2 | 2024-10-30 | NCT06275620 |